Diabetic drug Avandia in trouble



The antidiabetic drug rosiglitazone is in big trouble as the decisions from major regulatory bodies were announced today. The European Medicines Agency (EMA) announced today that it is recommending … [Read more...]


Heart(y) News February 26: Non-heart drugs that can affect your heart



Some noncardiovascular medications have the potential to affect cardiovascular function causing adverse effects that can potentially be life-threatening. The lesson learned from Vioxx was a hard one. … [Read more...]


It’s not all bad news for rosiglitazone



Remember the controversy about the diabetic drug rosiglitazone (market name Avandia)? Remember the issues surrounding the APPROACH Trial - Assessment on the Prevention of Progression by Rosiglitazone … [Read more...]


Treatment Methods for Diabetes



Exactly how diabetes is treated depends on a number of factors: which type the patient has, how severe it is, the age of the patient and others. Gestational diabetes, for example, that sometimes … [Read more...]


NOTE: The contents in this blog are for informational purposes only, and should not be construed as medical advice, diagnosis, treatment or a substitute for professional care. Always seek the advice of your physician or other qualified health professional before making changes to any existing treatment or program. Some of the information presented in this blog may already be out of date.